<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03502889</url>
  </required_header>
  <id_info>
    <org_study_id>SPANK Block</org_study_id>
    <nct_id>NCT03502889</nct_id>
  </id_info>
  <brief_title>Single Dose Adductor Canal Block vs SPANK Block for TKA</brief_title>
  <official_title>Single Dose Adductor Canal Block With SPANK (Sensory Posterior Articular Nerves of the Knee) Block Compared to Single Dose Adductor Canal Block and Pain Control After Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>San Antonio Uniformed Services Health Education Consortium</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>San Antonio Uniformed Services Health Education Consortium</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, randomized control trial to compare SPANK block combined with adductor
      canal block to adductor canal block alone in treatment of post-operative pain after total
      knee arthroplasty. The primary outcome is pain control, which will be measured throughout the
      post-operative course using morphine equivalents of opioid analgesics used during the first
      24 hours after surgery. Secondary outcomes include pain scores recorded at 4, 8, 12, 16, 20,
      and 24 hours post-operatively, cumulative pain score, incidence of post-operative nausea and
      vomiting, and extent of motor blockade. The study will aid in answering the question of
      whether SPANK block is an effective adjunct in preventing pain and decreasing opioid
      requirement after TKA.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2018</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative Opioid Consumption</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Amount of opioids used within the first 24 hours post-operatively, starting from when the patient leaves the operating room, measured in PO morphine equivalents</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative Pain Scores</measure>
    <time_frame>4, 8, 12, 16, and 24 hours postoperatively</time_frame>
    <description>Verbal pain score measured via numerical rating scale from 1-10 at 4 hrs, 8 hrs, 12hrs, 16hrs, and 24 hours.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first opioid use</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>The amount of time measured from when the patient leaves the operating room to the time when they receive their first dose of any opioid medication.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Osteo Arthritis Knee</condition>
  <condition>Pain, Postoperative</condition>
  <condition>Pain, Acute</condition>
  <arm_group>
    <arm_group_label>Adductor Canal Block Alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control arm to receive Adductor Canal Block without additional interventions Intervention: ropivacaine 0.5% 15cc injected under ultrasound guidance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SPANK Block Plus Adductor Canal Block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental arm to receive Adductor Canal Block plus SPANK Block (Sensory Posterior Articular Nerves of the Knee) without additional interventions Intervention: ropivacaine 0.5% 15cc injected under ultrasound guidance into the adductor canal plus 20cc ropivacaine 0.5% injected into the posterior tissues of the knee</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>SPANK Block (Sensory Posterior Articular Nerves of the Knee)</intervention_name>
    <description>Injection of local anesthetic into the tissues on the posterior aspect of the knee to provide sensory blockade of the articular nerves of the knee.</description>
    <arm_group_label>SPANK Block Plus Adductor Canal Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Adductor Canal Block</intervention_name>
    <description>Injection of local anesthetic into the inner thigh under ultrasound guidance to provide sensory blockade to the anterior aspect of the knee</description>
    <arm_group_label>Adductor Canal Block Alone</arm_group_label>
    <arm_group_label>SPANK Block Plus Adductor Canal Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine Hcl 0.5% Inj Vil 30Ml</intervention_name>
    <description>Amide local anesthetic, this concentration is commonly used to achieve surgical level anesthesia. The drug itself is not being studied and the same concentration will be used in all participants.</description>
    <arm_group_label>Adductor Canal Block Alone</arm_group_label>
    <arm_group_label>SPANK Block Plus Adductor Canal Block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pajunk sonoplex stim needle</intervention_name>
    <description>Echogenic needle used for ultrasound guided nerve blockade.</description>
    <arm_group_label>Adductor Canal Block Alone</arm_group_label>
    <arm_group_label>SPANK Block Plus Adductor Canal Block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients between the ages of 40 and 80 years old undergoing total knee arthroplasty
             amenable to peripheral nerve block for perioperative analgesia.

          -  BMI &lt;45

          -  ASA class III or less

        Exclusion Criteria:

          -  Inability to sign consent form

          -  Allergy to medications used in the study

          -  Repeat surgery

          -  History of seizure disorder

          -  Simultaneous bilateral TKA

          -  History of substance abuse

          -  BMI &gt;45

          -  Opioid consumption of greater or equal to 30mg morphine equivalents per day

          -  Age &lt;40 or &gt;80 years old

          -  ASA IV or greater

          -  Inability to use a PCA

          -  Inability to access the intrathecal space

          -  Infection at the site of injection (either for spinal or PNB)

          -  INR greater than or equal to 1.4
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Angela M Curell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>San Antonio Uniformed Services Health Education Consortium</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Angela M Curell, MD</last_name>
    <phone>(210) 220-7450</phone>
    <email>angela.m.curell2.mil@mail.mil</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gregory Stevens, MD</last_name>
    <phone>(210) 916-2014</phone>
    <email>gregory.j.stevens.mil@mail.mil</email>
  </overall_contact_backup>
  <reference>
    <citation>Terkawi AS, Mavridis D, Sessler DI, Nunemaker MS, Doais KS, Terkawi RS, Terkawi YS, Petropoulou M, Nemergut EC. Pain Management Modalities after Total Knee Arthroplasty: A Network Meta-analysis of 170 Randomized Controlled Trials. Anesthesiology. 2017 May;126(5):923-937. doi: 10.1097/ALN.0000000000001607.</citation>
    <PMID>28288050</PMID>
  </reference>
  <reference>
    <citation>Gao F, Ma J, Sun W, Guo W, Li Z, Wang W. Adductor Canal Block Versus Femoral Nerve Block for Analgesia After Total Knee Arthroplasty: A Systematic Review and Meta-analysis. Clin J Pain. 2017 Apr;33(4):356-368. doi: 10.1097/AJP.0000000000000402. Review.</citation>
    <PMID>27322397</PMID>
  </reference>
  <reference>
    <citation>Wang D, Yang Y, Li Q, Tang SL, Zeng WN, Xu J, Xie TH, Pei FX, Yang L, Li LL, Zhou ZK. Adductor canal block versus femoral nerve block for total knee arthroplasty: a meta-analysis of randomized controlled trials. Sci Rep. 2017 Jan 12;7:40721. doi: 10.1038/srep40721.</citation>
    <PMID>28079176</PMID>
  </reference>
  <reference>
    <citation>Karlsen AP, Wetterslev M, Hansen SE, Hansen MS, Mathiesen O, Dahl JB. Postoperative pain treatment after total knee arthroplasty: A systematic review. PLoS One. 2017 Mar 8;12(3):e0173107. doi: 10.1371/journal.pone.0173107. eCollection 2017. Review.</citation>
    <PMID>28273133</PMID>
  </reference>
  <reference>
    <citation>Li D, Ma GG. Analgesic efficacy and quadriceps strength of adductor canal block versus femoral nerve block following total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2016 Aug;24(8):2614-9. doi: 10.1007/s00167-015-3874-3. Epub 2015 Nov 26. Review.</citation>
    <PMID>26611901</PMID>
  </reference>
  <reference>
    <citation>Bauer MC, Pogatzki-Zahn EM, Zahn PK. Regional analgesia techniques for total knee replacement. Curr Opin Anaesthesiol. 2014 Oct;27(5):501-6. doi: 10.1097/ACO.0000000000000115. Review.</citation>
    <PMID>25111605</PMID>
  </reference>
  <reference>
    <citation>Pelt CE, Anderson AW, Anderson MB, Van Dine C, Peters CL. Postoperative falls after total knee arthroplasty in patients with a femoral nerve catheter: can we reduce the incidence? J Arthroplasty. 2014 Jun;29(6):1154-7. doi: 10.1016/j.arth.2014.01.006. Epub 2014 Jan 16.</citation>
    <PMID>24581899</PMID>
  </reference>
  <reference>
    <citation>Baratta JL, Gandhi K, Viscusi ER. Perioperative pain management for total knee arthroplasty. J Surg Orthop Adv. 2014 Spring;23(1):22-36. Review.</citation>
    <PMID>24641894</PMID>
  </reference>
  <reference>
    <citation>Kim DH, Lin Y, Goytizolo EA, Kahn RL, Maalouf DB, Manohar A, Patt ML, Goon AK, Lee YY, Ma Y, Yadeau JT. Adductor canal block versus femoral nerve block for total knee arthroplasty: a prospective, randomized, controlled trial. Anesthesiology. 2014 Mar;120(3):540-50. doi: 10.1097/ALN.0000000000000119.</citation>
    <PMID>24401769</PMID>
  </reference>
  <reference>
    <citation>Wasserstein D, Farlinger C, Brull R, Mahomed N, Gandhi R. Advanced age, obesity and continuous femoral nerve blockade are independent risk factors for inpatient falls after primary total knee arthroplasty. J Arthroplasty. 2013 Aug;28(7):1121-4. doi: 10.1016/j.arth.2012.08.018. Epub 2012 Dec 21.</citation>
    <PMID>23265274</PMID>
  </reference>
  <reference>
    <citation>Feibel RJ, Dervin GF, Kim PR, Beaul√© PE. Major complications associated with femoral nerve catheters for knee arthroplasty: a word of caution. J Arthroplasty. 2009 Sep;24(6 Suppl):132-7. doi: 10.1016/j.arth.2009.04.008. Epub 2009 Jun 24.</citation>
    <PMID>19553071</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 13, 2018</study_first_submitted>
  <study_first_submitted_qc>April 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2018</study_first_posted>
  <last_update_submitted>April 17, 2018</last_update_submitted>
  <last_update_submitted_qc>April 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>San Antonio Uniformed Services Health Education Consortium</investigator_affiliation>
    <investigator_full_name>Angela Curell</investigator_full_name>
    <investigator_title>Anesthesiology Resident</investigator_title>
  </responsible_party>
  <keyword>Total Knee Arthroplasty</keyword>
  <keyword>SPANK Block</keyword>
  <keyword>Adductor Canal Block</keyword>
  <keyword>Regional Anesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Acute Pain</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>If shared, will plan to provide. All IPD that underlie results in publication
Study Protocol
Statistical Analysis Plan (SAP)
Informed Consent Form (ICF)
Clinical Study Report (CSR)
Starting 6 months after publication</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

